Latest Loan Agreements News

Sprintex has advanced a promising trial with a major Dutch agribusiness, potentially unlocking €4.8 million in sales, while also securing a significant private-label contract in China’s booming aquaculture sector.

Latitude 66 has agreed to sell its 17.5% interest in the Greater Duchess Joint Venture for an upfront A$2 million, with potential for further contingent payments, while progressing exploration in Australia and Finland amid regulatory challenges.

Neurizon Therapeutics has secured a $1.5 million loan against its expected 2025 R&D tax rebate, boosting liquidity without diluting shareholders. This strategic move supports ongoing development of its neurodegenerative disease treatments.

Noble Helium advances its flagship North Rukwa helium project with a significant resource upgrade, rig exit at no cost, and new funding from key insiders, positioning for a leaner, data-driven drilling campaign.

Wingara AG has finalised the sale of its JC Tanloden machinery and reported a cash balance of $531,000 as of June 30, 2025, while the anticipated Terra Firma transaction remains unresolved.

My Foodie Box Ltd reported a $1.39 million profit for FY24 following the sale of its meal kit business to MFB (WA) Pty Ltd, receiving a 40% stake and vendor financing arrangements. The company now seeks new assets to restore shareholder value amid ongoing financial uncertainties.

Minbos Resources has secured key financing and made significant construction strides on its Angolan phosphate fertilizer plant, while rolling out promising new fertilizer blends to support local agriculture.

New World Resources has locked in a US$6.5 million unsecured loan from Kinterra to advance its Antler Copper Project and support a pending takeover bid. The funding aims to cover critical permitting, land acquisition, and transaction costs.

Boss Energy has exceeded its FY25 production and cost targets at the Honeymoon Uranium Project, marking a major milestone of over 1 million pounds of uranium produced since commissioning. The company’s robust balance sheet and operational ramp-up position it well for growth amid a strengthening uranium market.

Openn Negotiation Ltd has successfully exited voluntary administration following a recapitalisation plan that included issuing new shares and securing a shareholder loan. Despite no substantive business activity in the latest quarter, the company is positioned to continue operations under new management.

Openn Negotiation Ltd reported a significantly reduced net loss of $3.93 million for FY24, exiting voluntary administration with new directors and a recapitalisation led by ST Holding 2 Pty Ltd. The company faces challenges in regaining ASX compliance and identifying new business operations.

Lumos Diagnostics has locked in a A$5 million secured loan facility to support working capital as it advances toward FDA CLIA waiver for its FebriDx® test, complementing a landmark US distribution deal.